Cost will be key for Novo Nordisk’s Wegovy pill, says Dr. Patel

CNBC’s “Fast Money” team discusses new obesity drug data and the market leaders, including Novo Nordisk and Eli Lilly, with Dr. Kavita Patel, NBC News and MSNBC medical contributor.